Lakefront Biotherapeutics NV (LKFT)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
21
$118.63M held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| Ameriprise Financial, Inc. | Aug 14, 2026 | $38.14M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Aug 14, 2026 | $18.02M |
| DME Capital Management, LP | Aug 14, 2026 | $14.47M |
| RENAISSANCE TECHNOLOGIES LLC | Aug 13, 2026 | $12.23M |
| Point72 Asset Management, L.P. | Aug 14, 2026 | $8.09M |
LKFT's filings are public. The insight is one click away.
Scrutar's AI reads every LKFT filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze LKFT filingsNo credit cardAI reports included on the free plan
Never miss a LKFT filing.
Get an email when LKFT files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 29, 2026Source: SEC EDGAR.